Logan P. Jones

Array ( [id] => 8042333 [patent_doc_number] => 20120070907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'METHOD TO DEPLETE MONOCLONAL ANTIBODIES IN A BIOLOGICAL SAMPLE' [patent_app_type] => utility [patent_app_number] => 12/890288 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070907.pdf [firstpage_image] =>[orig_patent_app_number] => 12890288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134282 [patent_doc_number] => 20110008250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Treatment of Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 12/886205 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16087 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008250.pdf [firstpage_image] =>[orig_patent_app_number] => 12886205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059408 [patent_doc_number] => 08545843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Treatment of vasculitis' [patent_app_type] => utility [patent_app_number] => 12/886171 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16092 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12886171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134434 [patent_doc_number] => 20110008336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Treatment of Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 12/886156 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16088 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008336.pdf [firstpage_image] =>[orig_patent_app_number] => 12886156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134436 [patent_doc_number] => 20110008338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Treatment of Autoimmune Diseases' [patent_app_type] => utility [patent_app_number] => 12/886185 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16086 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008338.pdf [firstpage_image] =>[orig_patent_app_number] => 12886185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134557 [patent_doc_number] => 20110008459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Universally applicable blood plasma' [patent_app_type] => utility [patent_app_number] => 12/923380 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1234 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008459.pdf [firstpage_image] =>[orig_patent_app_number] => 12923380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118600 [patent_doc_number] => 20110076273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'Highly Concentrated Pharmaceutical Formulations' [patent_app_type] => utility [patent_app_number] => 12/879486 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29027 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076273.pdf [firstpage_image] =>[orig_patent_app_number] => 12879486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6380323 [patent_doc_number] => 20100316652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/861741 [patent_app_country] => US [patent_app_date] => 2010-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11702 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316652.pdf [firstpage_image] =>[orig_patent_app_number] => 12861741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239844 [patent_doc_number] => 20120148581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'USE OF NKG2D INHIBITORS FOR TREATING CARDIOVASCULAR AND METABOLIC DISEASES, SUCH AS TYPE 2 DIABETES' [patent_app_type] => utility [patent_app_number] => 13/388023 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25827 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101659 [patent_doc_number] => 20110165151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE' [patent_app_type] => utility [patent_app_number] => 12/855827 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11106 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165151.pdf [firstpage_image] =>[orig_patent_app_number] => 12855827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101660 [patent_doc_number] => 20110165152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABINE AND/OR MITOXANTRONE' [patent_app_type] => utility [patent_app_number] => 12/855951 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13018 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165152.pdf [firstpage_image] =>[orig_patent_app_number] => 12855951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347288 [patent_doc_number] => 20120208211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'HUMANISED PSORIASIS MODEL' [patent_app_type] => utility [patent_app_number] => 13/390281 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6987 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6269426 [patent_doc_number] => 20100298753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'TARGETED APHERESIS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 12/847906 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1765 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298753.pdf [firstpage_image] =>[orig_patent_app_number] => 12847906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323486 [patent_doc_number] => 20120195895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => ' Fusion Protein of an Anti-CD20 Antibody Fab Fragment and Lidamycin, a Method for Preparing the Same, and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/387531 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8285 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391870 [patent_doc_number] => 20100303810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'METHOD FOR TREATING LUPUS' [patent_app_type] => utility [patent_app_number] => 12/842529 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28636 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303810.pdf [firstpage_image] =>[orig_patent_app_number] => 12842529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6446109 [patent_doc_number] => 20100279932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'BINDING CONSTRUCTS AND METHODS FOR USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/834707 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 88 [patent_no_of_words] => 126925 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279932.pdf [firstpage_image] =>[orig_patent_app_number] => 12834707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650829 [patent_doc_number] => 20110300098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY' [patent_app_type] => utility [patent_app_number] => 12/826099 [patent_app_country] => US [patent_app_date] => 2010-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25552 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300098.pdf [firstpage_image] =>[orig_patent_app_number] => 12826099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184133 [patent_doc_number] => 20120114646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'LYOPHILIZED FORMULATIONS FOR SMALL MODULAR IMMUNOPHARMACEUTICALS' [patent_app_type] => utility [patent_app_number] => 13/378751 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18533 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114646.pdf [firstpage_image] =>[orig_patent_app_number] => 13378751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6474264 [patent_doc_number] => 20100284906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Internalizing Anti-CD74 Antibodies and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/791418 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 22771 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284906.pdf [firstpage_image] =>[orig_patent_app_number] => 12791418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391844 [patent_doc_number] => 20100303806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Avian derivedantibodies' [patent_app_type] => utility [patent_app_number] => 12/800989 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14320 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303806.pdf [firstpage_image] =>[orig_patent_app_number] => 12800989 [rel_patent_id] =>[rel_patent_doc_number] =>)